Ewa Bernatowska

A Multi-Center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency

2022 | Lékařská fakulta v Hradci Králové

Publikace